Champions Oncology, Inc. (CSBR)
NASDAQ: CSBR · Real-Time Price · USD
4.137
-0.133 (-3.11%)
Dec 3, 2024, 12:26 PM EST - Market open
Champions Oncology Market Cap
Champions Oncology has a market cap or net worth of $56.24 million as of December 3, 2024. Its market cap has decreased by -25.31% in one year.
Market Cap
56.24M
Enterprise Value
62.80M
1-Year Change
-25.31%
Ranking
Category
Stock Price
$4.14
Market Cap Chart
Since February 2, 2007, Champions Oncology's market cap has increased from $10.70M to $56.24M, an increase of 425.61%. That is a compound annual growth rate of 9.75%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Dec 2, 2024 | 58.60M | -23.30% |
Dec 29, 2023 | 76.40M | 25.04% |
Dec 30, 2022 | 61.10M | -45.93% |
Dec 31, 2021 | 113.00M | -21.69% |
Dec 31, 2020 | 144.30M | 49.07% |
Dec 31, 2019 | 96.80M | 8.04% |
Dec 31, 2018 | 89.60M | 110.33% |
Dec 29, 2017 | 42.60M | 53.79% |
Dec 30, 2016 | 27.70M | -10.93% |
Dec 31, 2015 | 31.10M | -6.89% |
Dec 31, 2014 | 33.40M | -58.35% |
Dec 31, 2013 | 80.20M | 468.79% |
Dec 31, 2012 | 14.10M | -59.94% |
Dec 30, 2011 | 35.20M | 6.02% |
Dec 31, 2010 | 33.20M | 26.24% |
Dec 31, 2009 | 26.30M | -26.74% |
Dec 31, 2008 | 35.90M | -19.14% |
Dec 31, 2007 | 44.40M | 314.95% |
View and export this data all the way back to 2007.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
AlloVir | 62.70M |
Spero Therapeutics | 62.15M |
Protara Therapeutics | 62.10M |
Aileron Therapeutics | 61.96M |
InterCure | 61.76M |
Boundless Bio | 60.88M |
Apyx Medical | 60.61M |
Entera Bio | 60.40M |